Paul Perreault

Industry Partnership Fuels Research, Advocacy

PhRMA membership expands CSL Behring’s opportunity for cooperation between industry leaders.

CSL CEO at Utah Life Sciences Summit

At biotech event, Paul Perreault will talk about the company’s COVID-19 response – including a potential treatment now in a c…

Three Quotes About an Unprecedented Year

When CSL Limited announced its end-of-year results, company leaders took stock of where we’ve been and where we’re headed.

Watch Online: CSL CEO at a White House Roundtable

Perreault made the case for a plasma-based hyperimmune to treat COVID-19.

CEO Paul Perreault at White House Roundtable

Perreault, representing the plasma industry, said an antibody treatment depends on additional donations from recovered patien…

CSL CEO: Don't Rush the COVID-19 Vaccine

Joining scientists and medical experts, Perreault urges rigor, precision and the necessary time to ensure vaccine safety.

Dealing With Challenges Head-On

CSL Limited CEO Paul Perreault offers a message of encouragement during the COVID-19 pandemic.

Podcast With CSL CEO Paul Perreault

“I want to make sure that we’re all supporting each other, practicing self-care, and if anybody reaches out, we’re there to t…

‘Our Promises Are Never Rare’

CSL’s CEO reflects on the importance of recognizing Rare Disease Day.

Four Academic Partnerships We're Excited About

Around the world, CSL is building creative partnerships with universities and research institutions.

CSL Limited Marks 25 Years on the ASX

Leaders ring the opening bell in Sydney and reflect on the company’s transformation into a global biotechnology business.

Behind the Scenes With Our CEO

It’s lights, camera, action as CSL chief Paul Perreault films employee messages in our U.S. studio.